Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EPZM | AMGN | GILD | VRTX | REGN |
| Company | Epizyme Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4900 | 264.63 | 66.25 | 394.72 | 913.97 |
| High | 1.5000 | 269.38 | 66.83 | 396.98 | 920.73 |
| Low | 1.4700 | 260.68 | 66.16 | 391.25 | 891.46 |
| Last | 1.4700 | 268.93 | 66.76 | 394.28 | 896.82 |
| Change | -0.0200 | +6.18 | +0.60 | +0.80 | +2.83 |
| % Change | -1.34% | +2.35% | +0.91% | +0.20% | +0.32% |
| Volume | 22,276,000 | 3,380,000 | 10,656,899 | 1,342,000 | 507,400 |
| 20-Day Average Volume | 3,364,145 | 2,246,420 | 6,455,915 | 931,820 | 437,680 |
| Previous Close | 1.4900 | 262.75 | 66.16 | 393.48 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4840 | 272.56 | 69.90 | 405.52 | 935.18 |
| 20-Day Raw Stochastic | 25.00% | 29.59% | 10.79% | 10.74% | 7.35% |
| 20-Day Relative Strength | 64.92% | 43.95% | 31.30% | 37.76% | 34.73% |
| Weighted Alpha | -67.50 | +7.67 | -24.32 | +15.95 | +12.43 |
| Today's Opinion | 8% Buy | 56% Sell | 100% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 24% Buy | 56% Sell | 100% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 8% Buy | 8% Sell | 72% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.68% since 08/04/22 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -0.57% since 04/12/24 | -0.87% since 04/12/24 |
| Low | 1.4700 on 08/11/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.5300 on 08/08/22 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | unch since 07/11/22 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | -5.04% since 03/19/24 | -6.94% since 03/19/24 |
| Low | 1.4500 on 08/04/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.5300 on 08/08/22 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +214.30% since 05/11/22 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | -9.37% since 01/19/24 | -3.92% since 01/19/24 |
| Low | 0.4110 on 06/01/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.5800 on 06/27/22 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -9.82% since 02/11/22 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +8.08% since 10/19/23 | +10.90% since 10/19/23 |
| Low | 0.4110 on 06/01/22 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 1.7650 on 03/03/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 247,444 | 140,812,720 | 82,374,304 | 101,698,464 | 98,126,128 |
| Shares Outstanding, K | 168,329 | 535,919 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 37,430,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -251,120,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 8,700,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -55,510,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | -0.41 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 08/09/22 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 08/08/22 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 29.25 | 23.98 |